PEOPLE - Symphony Medical makes appointment:
This article was originally published in Clinica
Raymond Cohen has been appointed CEO and a member of the board of directors for Symphony Medical (Laguna Hills, California). Mr Cohen joins the biotherapeutic products firm from Cardiac Science - a manufacturer of automatic public-access defibrillators - where he was CEO for nine years. He is a director at BioLife Solutions (cryopreservation products for human cell and tissue preservation) and Syncroness (contract engineering and product development), and acts as advisor for the College of Osteopathic Medicine, Western University of Health Sciences (California).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.